Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06571747 · ClinicalTrials.gov registry record · NA
Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement
A NA study of Cardiovascular Diseases and Influenza, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 3,668,428
- Enrollment target
- 2
- Study locations
NCT06571747 is a NA study of Cardiovascular Diseases and Influenza that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 3,668,428 participants, above the 14,746-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (24777% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06571747, a NA study of Cardiovascular Diseases and Influenza, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,668,428 participants
- Enrollment target
- 2
- Study locations
Study Summary
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed. KP VACCINATE is a multicenter, sequential, individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs. usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Mid Atlantic States (KPMAS) eligible members during the 2024-2025 influenza season.
Conditions Studied
Interventions
- BEHAVIORAL Cardiovascular-Focused Nudge Communication
Study Locations (2)
California
- Kaiser Permanente Northern California - Pleasanton
Maryland
- Kaiser Permanente Mid Atlantic States - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,668,428 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06571747
The ClinicalTrials.gov registry entry for NCT06571747 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3,668,428 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 14,746-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (24777% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Cardiovascular-Focused Nudge Communication is the first listed.
NCT06571747 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Maryland.
Frequently Asked Questions
What is clinical trial NCT06571747 about?
NCT06571747 is a clinical study titled "Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement". In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccinat...
What is the current status of trial NCT06571747?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,668,428 participants. The study started on 2024-09-05. Estimated completion is 2026-03-31.
What conditions does trial NCT06571747 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Influenza, Behavior, Social.
What interventions are being tested in trial NCT06571747?
The interventions under investigation include: Cardiovascular-Focused Nudge Communication (BEHAVIORAL).
Who is sponsoring clinical trial NCT06571747?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06571747 being conducted?
This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.